These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3978249)

  • 1. Nandrolone decanoate added to tamoxifen in the treatment of advanced breast cancer.
    Heinonen E; Alanko A; Gröhn P; Rissanen P
    Breast Cancer Res Treat; 1985; 5(1):75-80. PubMed ID: 3978249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal treatment of advanced breast cancer. A randomized trial of tamoxifen versus nandrolone decanoate.
    Kellokumpu-Lehtinen P; Huovinen R; Johansson R
    Cancer; 1987 Nov; 60(10):2376-81. PubMed ID: 3664426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined tamoxifen and anabolic steroid as primary treatment for breast carcinoma in the elderly.
    Pain JA; Wickremesinghe SS; Bradbeer JW
    Eur J Surg Oncol; 1990 Jun; 16(3):225-8. PubMed ID: 2347416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.
    Alanko A; Heinonen E; Scheinin T; Tolppanen EM; Vihko R
    Cancer; 1985 Oct; 56(7):1696-700. PubMed ID: 4027900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
    Chlebowski RT; Herrold J; Ali I; Oktay E; Chlebowski JS; Ponce AT; Heber D; Block JB
    Cancer; 1986 Jul; 58(1):183-6. PubMed ID: 3518910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis.
    Flicker L; Hopper JL; Larkins RG; Lichtenstein M; Buirski G; Wark JD
    Osteoporos Int; 1997; 7(1):29-35. PubMed ID: 9102059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nandrolone decanoate in NZB/W mice treated concomitantly with maintenance doses of dexamethasone sodium phosphate.
    Verheul HA; Deckers GH; Schuurs AH
    Int J Immunopharmacol; 1985; 7(2):249-54. PubMed ID: 4008140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women.
    Bird HA; Burkinshaw L; Pearson D; Atkinson PJ; Leatham PA; Hill J; Raven A; Wright V
    Ann Rheum Dis; 1987 Mar; 46(3):237-43. PubMed ID: 3555359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions.
    Geusens P; Dequeker J; Verstraeten A; Nijs J; Van Holsbeeck M
    Maturitas; 1986 Dec; 8(4):281-9. PubMed ID: 3574141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer.
    Mouridsen HT; Palshof T; Rose C
    Recent Results Cancer Res; 1980; 71():169-77. PubMed ID: 6988913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nandrolone decanoate and 1-alpha-hydroxy-calciferol on patients with vertebral osteoporotic collapse. A double-blind clinical trial.
    Lyritis GP; Androulakis C; Magiasis B; Charalambaki Z; Tsakalakos N
    Bone Miner; 1994 Dec; 27(3):209-17. PubMed ID: 7696887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer.
    Gundersen S; Kvinnsland S; Lundgren S; Klepp O; Lund E; Børmer O; Høst H
    Breast Cancer Res Treat; 1990 Nov; 17(1):45-50. PubMed ID: 2151369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients.
    Gaughan WJ; Liss KA; Dunn SR; Mangold AM; Buhsmer JP; Michael B; Burke JF
    Am J Kidney Dis; 1997 Oct; 30(4):495-500. PubMed ID: 9328363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.
    Fisher B; Redmond C; Brown A; Wickerham DL; Wolmark N; Allegra J; Escher G; Lippman M; Savlov E; Wittliff J
    J Clin Oncol; 1983 Apr; 1(4):227-41. PubMed ID: 6366135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nandrolone decanoate on bone mass in established osteoporosis.
    Passeri M; Pedrazzoni M; Pioli G; Butturini L; Ruys AH; Cortenraad MG
    Maturitas; 1993 Nov; 17(3):211-9. PubMed ID: 8133796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.
    Geusens P
    Clin Rheumatol; 1995 Sep; 14 Suppl 3():32-9. PubMed ID: 8846659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
    Gill PG; Gebski V; Snyder R; Burns I; Levi J; Byrne M; Coates A
    Ann Oncol; 1993 Nov; 4(9):741-4. PubMed ID: 8280654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise and supraphysiological dose of nandrolone decanoate increase apoptosis in spermatogenic cells.
    Shokri S; Aitken RJ; Abdolvahhabi M; Abolhasani F; Ghasemi FM; Kashani I; Ejtemaeimehr S; Ahmadian S; Minaei B; Naraghi MA; Barbarestani M
    Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):324-30. PubMed ID: 20002066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis.
    Need AG; Horowitz M; Walker CJ; Chatterton BE; Chapman IC; Nordin BE
    Bone; 1989; 10(1):3-6. PubMed ID: 2736154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adriamycin, cyclophosphamide, ftorafur and tamoxifen (ACFT) in patients with advanced breast cancer].
    Imajo K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Ozeki H; Nagamine D; Shinagawa K; Fukutani H
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):121-6. PubMed ID: 3122665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.